Search Results - "Lechanteur, C."

Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases by Grégoire, C., Lechanteur, C., Briquet, A., Baudoux, É., Baron, F., Louis, E., Beguin, Y.

“…Summary Background Inflammatory bowel diseases (IBD) are chronic relapsing diseases in which pro‐inflammatory immune cells and cytokines induce intestinal…”
Get full text

Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion by Erpicum, Pauline, Detry, Olivier, Weekers, Laurent, Bonvoisin, Catherine, Lechanteur, Chantal, Briquet, Alexandra, Beguin, Yves, Krzesinski, Jean-Marie, Jouret, François

“…Acute kidney injury (AKI) represents a worldwide public health issue of increasing incidence, with a significant morbi-mortality. AKI treatment mostly relies…”
Get full text

P0052 : Infusion of third-party mesenchymal stromal cells after liver transplantation: A phase i, open-label, clinical study by Detry, O, Vandermeulen, M, Delbouille, M.-H, Deroover, A, Somja, J, Bletard, N, Briquet, A, Lechanteur, C, Beguin, Y

Get full text

Combined suicide and cytokine gene therapy for peritoneal carcinomatosis by Lechanteur, C, Delvenne, P, Princen, F, Lopez, M, Fillet, G, Gielen, J, Merville, M-P, Bours, V

“…BACKGROUND Gene therapy is a novel approach for the treatment of cancers, and tumours disseminated in the peritoneal cavity are suitable for in situ delivery…”
Get full text

P293 Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study by Vieujean, S, Loly, J P, Boutaffala, L, Pariente, B, Reenaers, C, Briquet, A, Lechanteur, C, Beguin, Y, Louis, E

“…Abstract Background Intestinal fibrosis is a common complication of Crohn’s disease (CD) leading to progressive bowel stricture formation. Mesenchymal stem…”
Get full text

Cellular immunotherapy at the University Hospital of Liege : advances, challenges and prospects by Grégoire, C, Servais, S, Willems, E, Baudoux, E, Lechanteur, C, Briquet, A, Bettonville, V, Detry, O, Erpicum, P, Jouret, F, Louis, E, Baron, F, Beguin, Y

“…Cellular immunotherapy consists in using the cells of the immune system as a therapeutic weapon. In this constantly evolving field, the therapeutic strategies…”
Get more information

HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis by LECHANTEUR, C, PRINCEN, F, LO BUE, S, DETROZ, B, FILLET, G, GIELEN, J, BOURS, V, MERVILLE, M.-P

“…Peritoneal carcinomatosis is a common clinical situation which, in most cases, cannot be eradicated by surgery or chemotherapy. The feasibility of an…”
Get full text

Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis by PRINCEN, F, LECHANTEUR, C, LOPEZ, M, ROCOUX, G, DETROZ, B, GIELEN, J, FILLET, G, MERVILLE, M.-P, BOURS, V

“…Peritoneal carcinomatosis is a common clinical situation that requires novel therapeutic approaches. We investigated the efficiency of an HSVtk gene therapy…”
Get full text

Mesenchymal Stem Cell Infusion As Prevention For Graft Rejection And Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning From HLA-Mismatched Donors: A Pilot Study by Baron, F, Willems, E, Lechanteur, C, Baudoux, E, Frere, P, Hafraoui, K, Fillet, G, Beguin, Y

Get full text

HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis by Lechanteur, C, Princen, F, Lo Bue, S, Detroz, B, Fillet, G, Gielen, J, Bours, V, Merville, M P

Get more information

Influence des glucocorticoïdes sur les caractéristiques de la sénescence cellulaire dans les fibroblastes synoviaux d’origine arthrosique by Malaise, O., Paulissen, G., Deroyer, C., Ciregia, F., Poulet, C., Lechanteur, C., Brondello, J.M., De Seny, D., Malaise, M.

Get full text

Mesenchymal stromal cells and organ transplantation by Detry, O, Jouret, F, Vandermeulen, M, Erpicum, P, Delens, L, Grégoire, C, Briquet, A, Weekers, L, Baudoux, E, Lechanteur, C, Beguin, Y

“…Mesenchymal stromal cells (MSC) are multipotent and self-renewing cells. MSC are studied for their in vivo and in vitro immunomodulatory effects, in the…”
Get more information

Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversustumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning by Baron, F, Willems, E, Lechanteur, C, Baudoux, E, Frere, P, Vanbellinghen, J.-F, Bruck, F, Gothot, A, Hafraoui, K, Fillet, G, Beguin, Y

“…Background: Results of nonmyeloablative HCT in pts with HLA-mismatched donors have been disappointing due to high incidence of graft rejection and severe acute…”
Get full text

Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale au stade préfracturaire: étude randomisée by Hauzeur, J.P., Toungouz, M., Lechanteur, C., Beguin, Y., Baudoux, E., De Maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., Gangji, V.

Get full text

Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas by Robe, Pierre, Nguyen-Khac, Minh-Tuan, Lambert, Frederic, Lechanteur, Chantal, Jolois, Olivier, Ernst-Gengoux, Patricia, Rogister, Bernard, Bours, Vincent

“…The efficacy of HSV-TK/ganciclovir-based gene therapy on malignant gliomas largely relies on the amplitude of the bystander effect. In these experiments, the…”
Get full text

Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis by LECHANTEUR, Chantal, JACOBS, Nathalie, GREIMERS, Roland, BENOIT, Valerie, DEREGOWSKI, Valerie, CHARIOT, Alain, MERVILLE, Marie-Paule, BOURS, Vincent

“…Hypoxia, a common feature of solid tumors, is a direct stress that triggers apoptosis in many cell types. Poor or irregular tumor vascularization also leads to…”
Get full text

A Cell Type-specific and Gap Junction-independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-mediated Bystander Effect by PRINCEN, F, ROBE, P, LECHANTEUR, C, MESNIL, M, RIGO, J.-M, GIELEN, J, MERVILLE, M.-P, BOURS, V

“…Tumor cells expressing the herpes simplex virus type 1 thymidine kinase (HSV- tk ) gene are killed by nucleoside analogues such as ganciclovir (GCV). GCV…”
Get full text

Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis by Bentires-Alj, M, Hellin, A C, Lechanteur, C, Princen, F, Lopez, M, Fillet, G, Gielen, J, Merville, M P, Bours, V

“…Gene therapy is a novel therapeutic approach that might soon improve the prognosis of some cancers. We investigated the feasibility of cytosine deaminase (CD)…”
Get full text

THÉRAPIE CELLULAIRE EN PATHOLOGIE OSSEUSE: Synthèse 2008, Samedi 11 octobre by HAUZEUR, J. P, VAN CAUWENBERGE, H, MALAISE, M, BAUDOUX, E, LECHANTEUR, C, GANGJI, V

Get full text

Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells by Lechanteur, C, Moutschen, M, Princen, F, Lopez, M, Franzen, E, Gielen, J, Bours, V, Merville, M P

“…Immunomodulating gene therapy for the treatment of malignant diseases is under extensive investigation. In this study, we induced an antitumoral immune…”
Get full text